Vanda Pharmaceuticals (VNDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 25,208 | -15,567 | -18,010 | -39,865 | 20,186 |
| Depreciation Amortization | 735 | 2,558 | 11,868 | 14,231 | 2,958 |
| Accounts receivable | -11,207 | 2,525 | -4,298 | -12,677 | -1,623 |
| Accounts payable and accrued liabilities | -618 | 5,953 | N/A | N/A | N/A |
| Other Working Capital | -7,790 | -26 | -11,108 | 29,639 | -33,199 |
| Other Operating Activity | 23,658 | 2,574 | 13,445 | 21,121 | -69,876 |
| Operating Cash Flow | $29,986 | $-1,983 | $-8,103 | $12,449 | $-81,554 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -368 | -1,664 | -1,407 | -2,527 | -769 |
| Purchase Of Investment | -282,395 | -148,135 | -165,405 | -193,111 | -93,343 |
| Sale Of Investment | 198,103 | 139,568 | 156,787 | 169,040 | 89,830 |
| Purchase Sale Intangibles | -25,000 | N/A | N/A | N/A | -8,000 |
| Other Investing Activity | -25,000 | 0 | 0 | 0 | -7,755 |
| Investing Cash Flow | $-109,660 | $-10,231 | $-10,025 | $-26,598 | $-12,037 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 107,126 | 5,251 | 7,751 | 4,374 | 90,164 |
| Other Financing Activity | 0 | 0 | 0 | -283 | -436 |
| Financing Cash Flow | $107,126 | $5,251 | $7,751 | $4,091 | $89,728 |
| Exchange Rate Effect | -38 | 42 | 5 | N/A | N/A |
| Beginning Cash Position | 34,335 | 41,256 | 51,628 | 60,901 | 64,764 |
| End Cash Position | 61,749 | 34,335 | 41,256 | 50,843 | 60,901 |
| Net Cash Flow | $27,414 | $-6,921 | $-10,372 | $-10,058 | $-3,863 |
| Free Cash Flow | |||||
| Operating Cash Flow | 29,986 | -1,983 | -8,103 | 12,449 | -81,554 |
| Capital Expenditure | -368 | -1,664 | -1,407 | -2,527 | -769 |
| Free Cash Flow | 29,618 | -3,647 | -9,510 | 9,922 | -82,323 |